German HTA Body: EU Legislative Reforms Must Do More To Incentivize Use Of Comparative Data
Executive Summary
IQWiG, Germany’s health technology assessment (HTA) body, is calling for EU legislative reforms to do more to promote better evidence that addresses the questions health systems and HTAs have about the added benefits of new medicines.
You may also be interested in...
EU’s Plans for Regulatory Data Protection ‘Unworkable’
The European Commission will have a fight on its hands when it comes to the data protection part of its proposals for EU pharma legislative reform.
Belgium Aims To Drive Biologic Competition Through Tendering
New tendering rules in Belgium aim to improve competition between biosimilars and originators, for example by setting contract durations for tendering contracts and limiting the criteria for such contracts.
Companies Need EU Funding To Cover ‘Enormous Expenditure’ Of Complying With Revised GMP Rules
Important updates to good manufacturing practice guidelines are likely to mean medicine shortages, warns a German pharmaceutical industry group.